Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma

Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

(2016) F. Bernuzzi et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase

(2016) Moustafa Sakr et al.   GENE

Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy

(2015) Guofeng Cheng   ADVANCED DRUG DELIVERY REVIEWS

Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management

(2015) Sumera Rizvi et al.   Clinical Gastroenterology and Hepatology

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma

(2015) Torsten Voigtländer et al.   PLoS One

MiR-150-5p Suppresses Colorectal Cancer Cell Migration and Invasion through Targeting MUC4

(2014) Wei-Hua Wang et al.   Asian Pacific Journal of Cancer Prevention

MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma

(2014) M. Ito et al.   BLOOD

Human bile contains MicroRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis

(2014) Ling Li et al.   HEPATOLOGY

miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb

(2014) Junlan Feng et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator

(2014) Runglawan Silakit et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Clinical relevance of circulating cell-free microRNAs in cancer

(2014) Heidi Schwarzenbach et al.   Nature Reviews Clinical Oncology

From Moderately Severe to Severe Hypertriglyceridemia Induced Acute Pancreatitis: Circulating MiRNAs Play Role as Potential Biomarkers

(2014) Fangmei An et al.   PLoS One

The Long and Short of MicroRNA

(2013) Luke A. Yates et al.   CELL

Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management

(2013) John E. Eaton et al.   GASTROENTEROLOGY

Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma

(2013) Sumera Rizvi et al.   GASTROENTEROLOGY

miR-150 Down-Regulation Contributes to the Constitutive Type I Collagen Overexpression in Scleroderma Dermal Fibroblasts via the Induction of Integrin β3

(2012) Noritoshi Honda et al.   AMERICAN JOURNAL OF PATHOLOGY

miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure

(2012) Fangmei An et al.   APOPTOSIS

Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma

(2012) William C. Palmer et al.   JOURNAL OF HEPATOLOGY

MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells

(2011) Sanjeev K. Srivastava et al.   CARCINOGENESIS

Cancer surveillance in patients with primary sclerosing cholangitis

(2011) Nataliya Razumilava et al.   HEPATOLOGY

The role of microRNAs in normal and malignant hematopoiesis

(2009) Diamantina Vasilatou et al.   EUROPEAN JOURNAL OF HAEMATOLOGY